GW Pharma CEO after new drug launch: It's 'important to distinguish between what's medicine and what's not' in cannabis

6:51 PM ET Thu, 1 Nov 2018

Jim Cramer hears from GW Pharmaceuticals CEO Justin Gover about his company's cannabis-based epilepsy treatment that just launched in the United States.